PRCT
Procept Biorobotics Corp
17.20$
+0.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +25.0% | -10.2% | +7.2% | +4.6% | +9.4% | +1.5% | +7.7% | +1.9% | +5.6% | +1.5% | +114.6% | – | |
| – | -6.5% | +25.6% | +27.7% | +6.6% | +6.7% | +11.3% | +20.3% | +19.1% | -25.2% | +20.6% | +111.2% | – | |
| – | – | – | – | – | – | – | – | – | – | -373.0% | – | – | |
| – | +50.8% | -77.7% | -46.4% | -76.4% | +377.2% | +56.4% | +52.6% | +2.4% | -35.5% | +57.5% | +101.3% | – | |
| – | +50.8% | -77.7% | -46.4% | -76.4% | +377.2% | +56.4% | +52.6% | +2.4% | -35.5% | +57.5% | +101.3% | – | |
| – | – | – | – | – | – | – | – | – | -118.5% | – | – | – | |
| – | -98.2% | -9.8% | +104.8% | -67.6% | +9,843.3% | -99.2% | +237.3% | -75.4% | +312.3% | -95.0% | +2,025.2% | – | |
| – | -122.3% | – | – | – | – | -112.8% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.